2 studies found for:    ION | Gilead [Lead] | Phase 3
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV
Condition: Chronic Hepatitis C Virus
Interventions: Drug: Ledipasvir/sofosbuvir;   Drug: RBV
2 Completed Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)
Condition: Chronic Hepatitis C Virus
Interventions: Drug: LDV/SOF;   Drug: RBV

Indicates status has not been verified in more than two years